Eagle Pharmaceuticals, Inc. ingeniso iyonke, umvuzo wengeniso kunye nentshukumo yotshintsho kwi US dollar namhlanje
Eagle Pharmaceuticals, Inc. kumaxesha ambalwa okunika ingxelo. Izinto eziguquliweyo ze Eagle Pharmaceuticals, Inc. ingeniso iyonke itshintshiwe -8 667 000 $ kwisithuba sokugqibela. Ingeniso yengeniso, ingeniso kunye nezinto eziguqukayo - ezona zalathiso ziphambili zemali Eagle Pharmaceuticals, Inc.. Igrafu yengxelo yemali ye Eagle Pharmaceuticals, Inc.. Itshathi yengxelo yemali ibonisa amaxabiso avela 30/06/2017 ukuya 31/03/2021. Lonke ulwazi kwi Eagle Pharmaceuticals, Inc. ingeniso iyonke kule tshathi yenziwa ngohlobo lwemivalo etyheli.
|
|
Umhla weNgxelo
|
Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
kwaye
Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
|
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
kwaye
Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
|
|
31/03/2021 |
41 249 000 $ |
-17.146 % ↓ |
-421 000 $ |
-104.692 % ↓ |
|
31/12/2020 |
49 916 000 $ |
-10.95 % ↓ |
8 057 000 $ |
-36.00477 % ↓ |
|
30/09/2020 |
49 928 000 $ |
-2.745 % ↓ |
7 059 000 $ |
-49.722 % ↓ |
|
30/06/2020 |
41 938 000 $ |
-29.273 % ↓ |
-256 000 $ |
-109.628 % ↓ |
|
31/03/2019 |
49 785 000 $ |
-
|
8 973 000 $ |
-
|
|
31/12/2018 |
56 054 000 $ |
-
|
12 590 000 $ |
-
|
|
30/09/2018 |
51 337 000 $ |
-
|
14 040 000 $ |
-
|
|
30/06/2018 |
59 296 000 $ |
-
|
2 659 000 $ |
-
|
|
31/03/2018 |
46 626 000 $ |
-
|
2 616 000 $ |
-
|
|
31/12/2017 |
46 785 000 $ |
-
|
9 085 000 $ |
-
|
|
30/09/2017 |
63 021 000 $ |
-
|
15 431 000 $ |
-
|
|
30/06/2017 |
50 108 000 $ |
-
|
4 503 000 $ |
-
|
|
|
Bonisa:
|
|
Ukuze
|
|
|
|
Umbiko wezezimali Eagle Pharmaceuticals, Inc., ishedyuli
Imihla yeengxelo zemali zamva nje Eagle Pharmaceuticals, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Imihla kunye nemihla yeengxelo zemali isekwa yimithetho yelizwe apho inkampani isebenza khona. Ingxelo yezezimali yamva nje ye Eagle Pharmaceuticals, Inc. iyafumaneka kwi-intanethi ngaloo mhla - 31/03/2021. Inzuzo eninzi Eagle Pharmaceuticals, Inc. yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo. Inzuzo eninzi Eagle Pharmaceuticals, Inc. na 30 394 000 $
|
|
|
Imihla yeengxelo zezimali Eagle Pharmaceuticals, Inc.
Ingeniso yokusebenza Eagle Pharmaceuticals, Inc. yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo. Ingeniso yokusebenza Eagle Pharmaceuticals, Inc. na -3 773 000 $ Imali engenayo Eagle Pharmaceuticals, Inc. yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo. Imali engenayo Eagle Pharmaceuticals, Inc. na -421 000 $ Iindleko zokusebenza Eagle Pharmaceuticals, Inc. ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo. Iindleko zokusebenza Eagle Pharmaceuticals, Inc. na 45 022 000 $
|
|
Iimpahla zangoku Eagle Pharmaceuticals, Inc. ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa. Iimpahla zangoku Eagle Pharmaceuticals, Inc. na 163 986 000 $ Imali ekhoyo Eagle Pharmaceuticals, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali ekhoyo Eagle Pharmaceuticals, Inc. na 105 229 000 $ Ubulungisa Eagle Pharmaceuticals, Inc. bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo. Ubulungisa Eagle Pharmaceuticals, Inc. na 191 078 000 $
|
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
30/06/2020
|
31/03/2019
|
31/12/2018
|
30/09/2018
|
30/06/2018
|
31/03/2018
|
31/12/2017
|
30/09/2017
|
30/06/2017
|
|
|
Inzuzo eninzi
Inzuzo eninzi yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo.
|
30 394 000 $ |
37 375 000 $ |
37 942 000 $ |
28 803 000 $ |
36 685 000 $ |
37 497 000 $ |
38 346 000 $ |
40 737 000 $ |
34 818 000 $ |
33 079 000 $ |
51 356 000 $ |
36 288 000 $ |
|
Ixabiso lentengo
Ixabiso lilonke iindleko zemveliso kunye nokuhanjiswa kwemveliso kunye neenkonzo zenkampani.
|
10 855 000 $ |
12 541 000 $ |
11 986 000 $ |
13 135 000 $ |
13 100 000 $ |
18 557 000 $ |
12 991 000 $ |
18 559 000 $ |
11 808 000 $ |
13 706 000 $ |
11 665 000 $ |
13 820 000 $ |
|
Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
|
41 249 000 $ |
49 916 000 $ |
49 928 000 $ |
41 938 000 $ |
49 785 000 $ |
56 054 000 $ |
51 337 000 $ |
59 296 000 $ |
46 626 000 $ |
46 785 000 $ |
63 021 000 $ |
50 108 000 $ |
|
Ingeniso yokusebenza
Ingeniso yokusebenza iyimali evela kwingqesho yenkampani. Umzekelo, umthengisi wenza iholo ngenjongo yokuthengiswa kweempahla, kwaye ugqirha uyafumana inzuzo kwiinkonzo zonyango azinikezelayo.
|
- |
- |
- |
- |
49 785 000 $ |
56 054 000 $ |
51 337 000 $ |
59 296 000 $ |
46 626 000 $ |
46 785 000 $ |
63 021 000 $ |
50 108 000 $ |
|
Ingeniso yokusebenza
Ingeniso yokusebenza yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo.
|
-3 773 000 $ |
9 793 000 $ |
15 417 000 $ |
3 709 000 $ |
12 169 000 $ |
16 162 000 $ |
18 493 000 $ |
9 485 000 $ |
2 305 000 $ |
10 319 000 $ |
25 733 000 $ |
5 902 000 $ |
|
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
|
-421 000 $ |
8 057 000 $ |
7 059 000 $ |
-256 000 $ |
8 973 000 $ |
12 590 000 $ |
14 040 000 $ |
2 659 000 $ |
2 616 000 $ |
9 085 000 $ |
15 431 000 $ |
4 503 000 $ |
|
Iindleko zeR & D
Iindleko zophando nophuhliso - iindleko zophando ukuphucula iimveliso kunye neenkqubo okanye ukuphuhlisa iimveliso kunye nemigaqo emitsha.
|
14 288 000 $ |
9 395 000 $ |
4 828 000 $ |
7 135 000 $ |
6 375 000 $ |
5 859 000 $ |
5 975 000 $ |
15 265 000 $ |
17 320 000 $ |
9 444 000 $ |
8 954 000 $ |
6 684 000 $ |
|
Iindleko zokusebenza
Iindleko zokusebenza ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo.
|
45 022 000 $ |
40 123 000 $ |
34 511 000 $ |
38 229 000 $ |
37 616 000 $ |
39 892 000 $ |
32 844 000 $ |
49 811 000 $ |
32 513 000 $ |
22 760 000 $ |
25 623 000 $ |
30 386 000 $ |
|
Iimpahla zangoku
Iimpahla zangoku ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa.
|
163 986 000 $ |
166 065 000 $ |
163 796 000 $ |
168 436 000 $ |
182 229 000 $ |
163 844 000 $ |
197 770 000 $ |
201 596 000 $ |
168 820 000 $ |
188 697 000 $ |
182 154 000 $ |
123 866 000 $ |
|
Ixabiso lilonke
Inani elipheleleyo leempahla lilingana nemali epheleleyo yemali yentlangano, amanqaku amatyala kunye nempahla ebonakalayo.
|
259 968 000 $ |
253 190 000 $ |
248 161 000 $ |
256 710 000 $ |
259 452 000 $ |
238 603 000 $ |
268 788 000 $ |
273 937 000 $ |
249 296 000 $ |
270 060 000 $ |
266 890 000 $ |
220 179 000 $ |
|
Imali ekhoyo
Imali ekhoyo yimali yonke imali egcinwe yinkampani ngosuku lombiko.
|
105 229 000 $ |
103 155 000 $ |
89 681 000 $ |
108 213 000 $ |
102 139 000 $ |
78 791 000 $ |
91 226 000 $ |
100 247 000 $ |
95 670 000 $ |
114 657 000 $ |
97 545 000 $ |
55 385 000 $ |
|
Ityala langoku
Ithuba langoku liyinxalenye yetyala elihlawulelwa kunyaka (iinyanga ezili-12) kwaye luboniswe njengemfanelo ekhoyo kunye nenxalenye yemali esebenzayo.
|
- |
- |
- |
- |
44 222 000 $ |
39 686 000 $ |
35 411 000 $ |
47 738 000 $ |
6 250 000 $ |
4 875 000 $ |
5 000 000 $ |
- |
|
Iyonke imali
Ingqikithi yemali yintlawulo yemali yonke inkampani enayo kwiingxelo zayo, kubandakanywa imali encinci kunye nemali egcinwe ebhankini.
|
- |
- |
- |
- |
- |
- |
- |
- |
95 670 000 $ |
114 657 000 $ |
97 545 000 $ |
55 385 000 $ |
|
Ityala elipheleleyo
Iityala ezipheleleyo zidibeneyo zetyala elifutshane kunye nexesha elide. Iimali ezifutshane zesikhashana zizo kufuneka zibuyiselwe ngaphakathi konyaka. Ithuba lexesha elide liquka iimeko zonke ezimele zihlawulwe emva konyaka omnye.
|
- |
- |
- |
- |
84 091 000 $ |
77 841 000 $ |
74 723 000 $ |
88 206 000 $ |
47 874 000 $ |
47 780 000 $ |
48 936 000 $ |
- |
|
Umlinganiselo weetyala
Ixabiso elipheleleyo lexabiso lemali lilonke lixabiso lemali elibonisa ipesenti yeefayili zeenkampani ezimele njengetyala.
|
- |
- |
- |
- |
32.41 % |
32.62 % |
27.80 % |
32.20 % |
19.20 % |
17.69 % |
18.34 % |
- |
|
Ubulungisa
Ubulungisa bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo.
|
191 078 000 $ |
186 011 000 $ |
172 787 000 $ |
183 964 000 $ |
175 361 000 $ |
160 762 000 $ |
194 065 000 $ |
185 731 000 $ |
178 177 000 $ |
179 144 000 $ |
171 077 000 $ |
165 362 000 $ |
|
Ukuhamba kwemali
Ukuhamba kwemali yintlawulo enemali yemali kunye nokulingana kwemali ejikelezayo kwintlangano.
|
- |
- |
- |
- |
26 181 000 $ |
38 108 000 $ |
3 688 000 $ |
5 667 000 $ |
4 921 000 $ |
25 921 000 $ |
7 886 000 $ |
37 548 000 $ |
|
|
Ingxelo yemali yakutshanje kwingeniso ye Eagle Pharmaceuticals, Inc. yayingu-31/03/2021. Ngokweengxelo zamuva malunga neziphumo zezimali ze-Eagle Pharmaceuticals, Inc., imali engenayo ye-Eagle Pharmaceuticals, Inc. yayingu-41 249 000 US dollar kwaye yaguqulwa ibe yi--17.146% ngokumalunga nomnyaka odlulileyo. Inzuzo yentlawulo ye Eagle Pharmaceuticals, Inc. kwikota yokugqibela yayingu--421 000 $, inzuzo yentengo ishintshwe ngu--104.692% xa kuthelekiswa nomnyaka odlulileyo.
|
